ArticleBriefings in bioinformatics2025
KansformerEPI: a deep learning framework integrating KAN and transformer for predicting enhancer-promoter interactions.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Protein-nucleic acid binding site prediction using interpretable Kolmogorov-Arnold networks with hypergraph representation learning.Bioinformatics (Oxford, England) · 2026Article
- Epigenetic research methods and animal models for intervertebral disc degeneration (Review).Molecular medicine reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Enhancer-promoter interaction (EPI) is a critical component of gene regulation. Accurately predicting EPIs across diverse cell types can advance our understanding of the molecular mechanisms behind transcriptional regulation and provide valuable insights into the onset and progression of related diseases. At present, large-scale genome-wide EPI predictions typically rely on computational approaches. However, most of these methods focus on predicting EPIs within a single cell line and lack a global perspective encompassing multiple cell lines. Furthermore, they often fail to fully account for the nonlinear relationships between features, leading to suboptimal prediction accuracy. In this study, we propose KansformerEPI, a global EPI prediction model designed for multiple cell lines. The model is built on Kansformer, an encoder that integrates KAN and Transformer, effectively capturing the nonlinear relationships among various epigenetic and sequence features. We utilized KansformerEPI to achieve cross-tissue prediction of EPIs across different cell types. This approach enhances the model's scalability, eliminating the complexity of designing separate prediction models for individual tissues. As a result, our model is applicable to various tissues, thereby reducing dependency on extensive datasets. Experimental results demonstrate that KansformerEPI surpasses existing methods such as TransEPI, TargetFinder, and SPEID in both accuracy and stability of EPI predictions across datasets including HMEC, IMR90, K562, and NHEK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.